www.fdanews.com/articles/176744-ivasculars-luminor-18-secures-ce-mark-approval
iVascular’s Luminor 18 Secures CE Mark Approval
May 20, 2016
iVascular’s Luminor 18 drug eluting balloon has gained CE mark approval, the company announced Thursday, with the device intended for lower limb angioplasty.
The balloon is compatible with 0.018-inch guidewires and combines low profile with drug eluting coating technology to lower procedure costs. Further, it expands the company’s existing Luminor portfolio.
Based in Barcelona, iVascular specializes in coronary and endovascular devices. — Anisa Jibrell